Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Leads Index Again

For the second week in a row, Bruker BioSciences led all gainers in the BCW Index with an increase of 10.8 percent for the five-day trading week ended Tuesday. Last Wednesday, the firm was mentioned in an article on the influential investment website The Motley Fool spotlighting companies with a high percentage of inside stock holders.
 
Bruker’s gains follow last week’s rise of 9.1 percent.
 
Shares of only five companies in the Index lost value for the week. Beckman Coulter and Bio-Rad Laboratories were the only two to lose more than 1 percent, with their shares dropping 1.34 and 1.26 percent, respectively.
 

Overall, the Index gained 2.57 percent for the tracking period. In comparison, the Dow Jones Industrial Average rose 3.2 percent, the Nasdaq gained 2.1 percent, and the Nasdaq Biotech Index increased .7 percent. The stock market received a major boost on Tuesday, when the Federal Reserve cut a key interest rate by .5 percent.

 
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Closing Price
(Sept. 18, 2007)
Starting Price
(Sept. 11, 2007)
% change
Affymetrix
AFFX
24.00
23.41
2.52
Agilent
A
37.20
36.31
2.45
Applied Biosystems
ABI
33.95
32.10
5.76
Beckman
BEC
71.28
72.25
-1.34
Becton Dickinson
BDX
79.25
77.71
1.98
Bio-Rad
BIO
84.48
85.56
-1.26
Bruker
BRKR
8.51
7.68
10.81
Caliper
CALP
5.62
5.41
3.88
Cepheid
CPHD
20.83
20.01
4.10
Illumina
ILMN
53.47
51.43
3.97
Invitrogen
IVGN
81.50
81.52
-0.02
Luminex
LMNX
15.59
14.99
4.00
MDS
MDZ
21.48
20.69
3.82
Millipore
MIL
76.53
73.63
3.94
PerkinElmer
PKI
28.59
27.42
4.27
Qiagen
QGEN
17.09
17.11
-0.12
Sequenom
SQNM
5.00
5.05
-0.99
Sigma-Aldrich
SIAL
46.74
43.86
6.57
Thermo
TMO
57.51
54.50
5.52
Third Wave
TWTI
8.43
8.11
3.95
Waters
WAT
66.46
63.62
4.46
BCW Index Average
40.17
39.16
2.57
The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.